| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.087 | 0.06 |